Quality Assurance and Acute Toxicities of a 2 Week Hypofractionated Palliative Radiotherapy Schedule used in a Prospective Phase I/II Study (HYPORT Study). Issue 3 (March 2017) - Chatterjee, S.; Saha, A.; Badgami, R.K.; Sen, P.; Midha, D.; Sinha, S.; Agarwal, S.; Ray, S.; Das, J.; Datta, S.S.; Mahata, A.; Mondal, S.; et al.